These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 19160441)

  • 41. Biowaiver monographs for immediate release solid oral dosage forms: metronidazole.
    Rediguieri CF; Porta V; G Nunes DS; Nunes TM; Junginger HE; Kopp S; Midha KK; Shah VP; Stavchansky S; Dressman JB; Barends DM
    J Pharm Sci; 2011 May; 100(5):1618-27. PubMed ID: 21374600
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Biowaiver Monograph for Immediate-Release Solid Oral Dosage Forms: Levocetirizine Dihydrochloride.
    Charoo NA; Abdallah DB; Ahmed DT; Abrahamsson B; Cristofoletti R; Langguth P; Mehta M; Parr A; Polli JE; Shah VP; Kambayashi A; Dressman J
    J Pharm Sci; 2023 Apr; 112(4):893-903. PubMed ID: 36581104
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Biowaiver monographs for immediate-release solid oral dosage forms: codeine phosphate.
    Dahan A; Wolk O; Zur M; Amidon GL; Abrahamsson B; Cristofoletti R; Groot DW; Kopp S; Langguth P; Polli JE; Shah VP; Dressman JB
    J Pharm Sci; 2014 Jun; 103(6):1592-600. PubMed ID: 24788239
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Biowaiver Monograph for Immediate-Release Solid Oral Dosage Forms: Sitagliptin Phosphate Monohydrate.
    Charoo NA; Abdallah DB; Bakheit AA; Haque KU; Hassan HA; Abrahamsson B; Cristofoletti R; Langguth P; Mehta M; Parr A; Polli JE; Shah VP; Tajiri T; Dressman J
    J Pharm Sci; 2022 Jan; 111(1):2-13. PubMed ID: 34597625
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Biowaiver Monograph for Immediate-Release Solid Oral Dosage Forms: Carbamazepine.
    García MA; Cristofoletti R; Abrahamsson B; Groot DW; Parr A; Polli JE; Mehta M; Shah VP; Tomakazu T; Dressman JB; Langguth P
    J Pharm Sci; 2021 May; 110(5):1935-1947. PubMed ID: 33610571
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Biowaiver Monograph for Immediate-Release Dosage Forms: Levamisole Hydrochloride.
    Kambayashi A; de Meijer M; Wegman K; van Veldhuizen C; Abrahamsson B; Cristofoletti R; Langguth P; Mehta M; Parr A; Polli JE; Shah VP; Dressman J
    J Pharm Sci; 2023 Mar; 112(3):634-639. PubMed ID: 36563854
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Biowaiver monographs for immediate release solid oral dosage forms: acetaminophen (paracetamol).
    Kalantzi L; Reppas C; Dressman JB; Amidon GL; Junginger HE; Midha KK; Shah VP; Stavchansky SA; Barends DM
    J Pharm Sci; 2006 Jan; 95(1):4-14. PubMed ID: 16307451
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Biowaiver Monographs for Immediate Release Solid Oral Dosage Forms: Proguanil Hydrochloride.
    Plöger GF; Abrahamsson B; Cristofoletti R; Groot DW; Langguth P; Mehta MU; Parr A; Polli JE; Shah VP; Tajiri T; Dressman JB
    J Pharm Sci; 2018 Jul; 107(7):1761-1772. PubMed ID: 29571740
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Biowaiver Monograph for Immediate-Release Solid Oral Dosage Forms: Isavuconazonium Sulfate.
    Plano D; Rudolph N; Saal C; Abrahamsson B; Cristofoletti R; Kambayashi A; Langguth P; Mehta M; Parr A; Polli JE; Shah VP; Charoo N; Dressman J
    J Pharm Sci; 2024 Feb; 113(2):386-395. PubMed ID: 37951471
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Biowaiver Monographs for Immediate Release Solid Oral Dosage Forms: Ribavirin.
    Goodarzi N; Barazesh Morgani A; Abrahamsson B; Cristofoletti R; Groot DW; Langguth P; Mehta MU; Polli JE; Shah VP; Dressman JB
    J Pharm Sci; 2016 Apr; 105(4):1362-9. PubMed ID: 26952879
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Biowaiver Monograph for Immediate-Release Solid Oral Dosage Forms: Ondansetron.
    Rajawat GS; Belubbi T; Nagarsenker MS; Abrahamsson B; Cristofoletti R; Groot DW; Langguth P; Parr A; Polli JE; Mehta M; Shah VP; Tajiri T; Dressman J
    J Pharm Sci; 2019 Oct; 108(10):3157-3168. PubMed ID: 31181225
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Biowaiver monographs for immediate release solid oral dosage forms: ibuprofen.
    Potthast H; Dressman JB; Junginger HE; Midha KK; Oeser H; Shah VP; Vogelpoel H; Barends DM
    J Pharm Sci; 2005 Oct; 94(10):2121-31. PubMed ID: 16136567
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Biowaiver Monographs for Immediate-Release Solid Oral Dosage Forms: Enalapril.
    Verbeeck RK; Kanfer I; Löbenberg R; Abrahamsson B; Cristofoletti R; Groot DW; Langguth P; Polli JE; Parr A; Shah VP; Mehta M; Dressman JB
    J Pharm Sci; 2017 Aug; 106(8):1933-1943. PubMed ID: 28435140
    [TBL] [Abstract][Full Text] [Related]  

  • 54. In Vitro-In Vivo Evaluation of Novel Co-spray Dried Rifampicin Phospholipid Lipospheres for Oral Delivery.
    Singh C; Koduri LV; Bhatt TD; Jhamb SS; Mishra V; Gill MS; Suresh S
    AAPS PharmSciTech; 2017 Jan; 18(1):138-146. PubMed ID: 26902373
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Nano-formulation of rifampicin with enhanced bioavailability: development, characterization and in-vivo safety.
    Singh H; Jindal S; Singh M; Sharma G; Kaur IP
    Int J Pharm; 2015 May; 485(1-2):138-51. PubMed ID: 25769294
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Plasma pooling to expedite bioequivalence estimation of rifampicin in fixed dose combinations.
    Panchagnula R; Parmar J; Kaur JK; Singh I; Bhade SR
    Methods Find Exp Clin Pharmacol; 2006 Apr; 28(3):161-7. PubMed ID: 16810342
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A critical review of the probable reasons for the poor variable bioavailability of rifampicin from anti-tubercular fixed-dose combination (FDC) products, and the likely solutions to the problem.
    Singh S; Mariappan TT; Shankar R; Sarda N; Singh B
    Int J Pharm; 2001 Oct; 228(1-2):5-17. PubMed ID: 11576764
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A bioequivalence comparison of two formulations of rifampicin (300- vs 150-mg capsules): An open-label, randomized, two-treatment, two-way crossover study in healthy volunteers.
    Chik Z; Basu RC; Pendek R; Lee TC; Mohamed Z
    Clin Ther; 2010 Sep; 32(10):1822-31. PubMed ID: 21194606
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Novel rifampicin-phospholipid complex for tubercular therapy: synthesis, physicochemical characterization and in-vivo evaluation.
    Singh C; Bhatt TD; Gill MS; Suresh S
    Int J Pharm; 2014 Jan; 460(1-2):220-7. PubMed ID: 24188983
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Gastroretentive delivery of rifampicin: in vitro mucoadhesion and in vivo gamma scintigraphy.
    Pund S; Joshi A; Vasu K; Nivsarkar M; Shishoo C
    Int J Pharm; 2011 Jun; 411(1-2):106-12. PubMed ID: 21458549
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.